Navigation Links
Body Weight Found To Influence PSA Levels

A new study shows obese men generally have lower prostate specific antigen levels than men of normal weight. // However researchers say this finding suggests the PSA test may not be as good at identifying early prostate cancer in such men.

Researchers studied about 2,800 men with no evidence of prostate cancer. Results showed PSA levels declined as weight increased. The association held true across all age groups and throughout all races. A study done in 2003 showed that men with the highest body mass indexes were 34-percent more likely to develop the disease than those with lower BMIs. Other studies have also shown poorer outcomes for obese men diagnosed with prostate cancer.

Hence researchers believe their present study suggests one reason why obese men with the disease fare worse than their thinner counterparts the reason being that low PSA levels mean they are diagnosed at a later stage and when the condition is more difficult to treat.

Thus researchers suggest that doctors take this factor into account when deciding if a PSA level deserves further investigation in order to assess whether consideration of BMI in PSA interpretation results in earlier detection and, ultimately, in better prostate carcinoma prognosis for obese men.
'"/>




Page: 1

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Weight-Loss Drinks Can Make You Gassy
3. Smoking Linked To Low Infant Birth Weight
4. Weight gain following smoking cessation not linked to Leptin
5. Helping Kids Attain a Healthy Weight
6. Weight-loss Products Dangerous
7. Weight and Blood Pressure
8. Low Birth Weight infants could have Problems in the Future
9. Excess Weight Can Affect Individuals as They Age
10. Low-Fat, High-Carb Diet Equally Effective In Weight Loss
11. Weight Gain Found To Increase The Risk Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has ... bony lump located on the forehead usually attributed to a facial fracture. Their appearance ... Dr. Shah has discovered an approach that is minimally invasive. He is an expert ...
(Date:4/21/2017)... ... , ... The adage “Show, don’t tell” applies perfectly to Green Builder Media’s ... VISION House demonstration project series. Manifesting the concept of right-sized living, the Flex House ... live affordably and abundantly without unduly taxing the resources of our beautiful planet. ...
(Date:4/21/2017)... ... 21, 2017 , ... The American Medical Student Association (AMSA) ... Recovery Education, from April 24 to April 28, 2017, dedicated to increasing awareness ... The mission of AWARE is to instill a compassionate, total health approach to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... quality-based imaging practices, is seeking candidates to serve on its Accreditation and ... , “RadSite’s ultimate mission is improving image quality and reducing patient ...
(Date:4/21/2017)... ... ... Each year, everyone is urged to give back to the earth on ... to a better future. However, supporting the environment should be an everyday practice. ... two to five times more polluted than outdoor air, reports the Environmental Protection Agency ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology: